essential thrombocythemia

Showing 1 - 25 of 63

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)

Not yet recruiting
  • Myeloproliferative Disorders
  • +3 more
  • (no location specified)
Nov 21, 2023

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

Recruiting
  • Myeloproliferative Neoplasm
  • +7 more
    • Hong Kong, Hong Kong
      Department of Medicine, Queen Mary Hospital
    May 21, 2023

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Atypical Chronic Myeloid

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +9 more
    • Los Angeles, California
    • +5 more
    Jan 27, 2023

    Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

    Active, not recruiting
    • Myeloproliferative Neoplasm
    • +4 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Jan 6, 2023

    Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma Trial in Baltimore (Fludarabine,

    Completed
    • Myelodysplastic Syndrome
    • +13 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Nov 2, 2022

    Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

    Recruiting
    • Myeloproliferative Neoplasm
    • +3 more
    • CALR allele burden quantification
    • Angers, France
      CHU Angers
    Nov 2, 2022

    Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

    Recruiting
    • Acute Myeloid Leukemia
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 18, 2022

    Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))

    Not yet recruiting
    • Essential Thrombocythemia
    • Ropeginterferon alfa-2b-njft (P1101)
    • (no location specified)
    Jul 28, 2022

    Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis Trial in Buffalo (drug, dietary supplement, other)

    Terminated
    • Essential Thrombocythemia
    • +2 more
    • Arsenic Trioxide
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2022

    Myelofibrosis, Essential Thrombocythemia, MPN Trial in New York (Peptide-based vaccine, Poly ICLC)

    Not yet recruiting
    • Myelofibrosis
    • +2 more
    • Peptide-based vaccine
    • Poly ICLC
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Jun 7, 2022

    Myeloproliferative Tumor, Essential Thrombocythemia, JAK2 Mutation Trial in Ottawa (Apixaban 2.5 MG Oral Tablet [ELIQUIS],

    Recruiting
    • Myeloproliferative Neoplasm
    • +5 more
    • Apixaban 2.5 MG Oral Tablet [ELIQUIS]
    • Aspirin 81 mg
    • Ottawa, Ontario, Canada
      The Ottawa Hospital
    Apr 19, 2022

    Essential Thrombocythemia Trial in Worldwide (IMG-7289)

    Active, not recruiting
    • Essential Thrombocythemia
    • Jacksonville, Florida
    • +25 more
    Apr 15, 2022

    Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

    Recruiting
    • Primary Myelofibrosis
    • +9 more
    • Observational
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 11, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +15 more
    • Hematopoietic Cell Transplantation
    • +7 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Apr 1, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Essential Thrombocythemia Trial in Worldwide (Ropeginterferon alfa-2b, Anagrelide)

    Recruiting
    • Essential Thrombocythemia
    • Phoenix, Arizona
    • +60 more
    Dec 30, 2021

    Essential Thrombocythemia Trial in Korea, Republic of (Anagre Cap.)

    Completed
    • Essential Thrombocythemia
    • Anagre Cap.
    • Goyang, Gyeonggi, Korea, Republic of
    • +20 more
    Jul 20, 2021

    Essential Thrombocythemia Trial in Tours (Anagrelide, Ruxolitinib (JAKAVI®), IFNa/ PegIFNa)

    Terminated
    • Essential Thrombocythemia
    • Tours, France
      FILO
    Jun 28, 2021

    Xagrid (FOX) Study In Adult Essential Thrombocythemia

    Completed
    • Essential Thrombocythemia
      • Paris, Cedex 13, France
      • +45 more
      Jun 7, 2021

      Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

      Active, not recruiting
      • Adult Acute Lymphoblastic Leukemia in Remission
      • +46 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 10, 2021

      Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission

      Completed
      • Hematopoietic/Lymphoid Cancer
      • +135 more
      • beclomethasone dipropionate
      • +4 more
      • Hackensack, New Jersey
      • +1 more
      Feb 1, 2021

      Essential Thrombocythemia, Polycythemia Vera Trial in Boston (Ruxolitinib)

      Not yet recruiting
      • Essential Thrombocythemia
      • Polycythemia Vera
      • Boston, Massachusetts
      • +2 more
      Nov 24, 2020